임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
60건 표시 (상위 60건)
- 1상모집 중단 (진행 중)· Type 2 Diabetes Mellitus (T2DM)Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of L03TD1 in Healthy Volunteers
리드: 셀트리온
- 1상완료· Healthy Male SubjectsA Study to Compare the Auto-injector and Pre-filled Syringe of CT-P52 in Healthy Male Subjects
리드: 셀트리온
- 단계 미표기모집 중· Chronic Spontaneous Urticaria (CSU)ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar
리드: 셀트리온
- 1상모집 중단 (진행 중)· Healthy ParticipantsStudy to Compare Pharmacokinetics and Safety of CT-P52 and US-licensed Taltz in Healthy Subjects
리드: 셀트리온
- 1상완료· Type 2 Diabetes Mellitus (T2DM)Phase I Study to Evaluate the Pharmacokinetics and Safety After Co-administration of L03RD1 and L03RD2 or Administration of CT-L03 in Healthy Volunteers
리드: 셀트리온
- 1상완료· Healthy Male SubjectsA Study to Compare the Auto-injector and Pre-filled Syringe of CT-P43 in Healthy Male Subjects
리드: 셀트리온
- 3상모집 중단 (진행 중)· Plaque PsoriasisA Study to Compare Efficacy and Safety of CT-P55 and Cosentyx in Patients With Moderate to Severe Psoriasis
리드: 셀트리온
- 단계 미표기모집 중· Crohn DiseaseROLL'YN-UST: an Observational Study in Patients Treated by Steqeyma®, an Ustekinumab Biosimilar
리드: 셀트리온
- 3상모집 중단 (진행 중)· Non Squamous Non Small Cell Lung CancerA Study to Compare Effects and Safety of CT-P51 and Keytruda in Patients With Previously Untreated Metastatic Lung Cancer
리드: 셀트리온
- 3상완료· Moderately to Severely Active Rheumatoid ArthritisA Phase 3 Study to Evaluate Efficacy & Safety of Subcutaneous CT-P13 in Patients With Moderate to Severe Active Rheumatoid Arthritis
리드: 셀트리온
- 4상모집 중· Type 2 DiabetesPioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes
협력: 셀트리온
- 해당없음모집 중· Type 2 DiabetesA Registry-based Randomized Controlled Trial in Type 2 Diabetes With Cardiovascular Risk Factors (REMATCH)
협력: 셀트리온, 종근당, 대웅제약
- 3상상태 미확인· Inflammatory Bowel DiseasesPharmacokinetics, Efficacy and Safety of CT-P13 Subcutaneous as Induction Therapy in Patients With Active CD or UC
협력: 셀트리온
- 4상모집 중· Inflammatory Bowel DiseasesSubcutaneous Infliximab After A Previous Intravenous Dose Optimization
협력: 셀트리온
- 1상완료· Healthy Male SubjectsTo Compare the Pharmacokinetics, Safety and Immunogenicity of CT-P55 and Cosentyx in Healthy Subjects
리드: 셀트리온
- 3상모집 중· Relapsing-remitting Multiple SclerosisA Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of CT-P53 and Ocrevus in Patients With Relapsing-remitting Multiple Sclerosis
리드: 셀트리온
- 3상초청 등록· Non-Alcoholic Fatty Liver DiseaseClinical Trial Assessing Godex Carnitine Orotate Complex in Nonalcoholic Fatty Liver Disease Patients for Efficacy
협력: 셀트리온
- 1상완료· Essential HypertensionA Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers
리드: 셀트리온
- 3상상태 미확인· Rheumatoid ArthritisA Study to Evaluate Usability of Subcutaneous Auto-injector of CT-P47 in Patients With Active Rheumatoid Arthritis
리드: 셀트리온
- 단계 미표기모집 중단 (진행 중)· Rheumatoid ArthritisA Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps
리드: 셀트리온
- 1상상태 미확인· Healthy SubjectsCompare the Auto-injector and Pre-filled Syringe of CT-P47 in Healthy Subjects
리드: 셀트리온
- 3상완료· Moderate to Severe Chronic Plaque PsoriasisTo Compare Pharmacokinetics, Efficacy, and Safety of CT-P17 With Humira in Patients With Moderate to Severe Chronic Plaque Psoriasis
리드: 셀트리온
- 3상완료· Rheumatoid ArthritisA Study to Compare Efficacy and Safety of CT-P47 and RoActemra in Patients With Rheumatoid Arthritis
리드: 셀트리온
- 2상조기 종료· Marginal Zone LymphomaPembrolizumab in MarginalzoneLymphoma A MULTICENTER OPEN LABEL SINGLE-ARM PHASE II STUDY
협력: 셀트리온
- 1상상태 미확인· Healthy SubjectsA Study to Compare the Pharmacokinetics and Safety of CT-P47 and RoActemra in Healthy Subjects
리드: 셀트리온
- 3상모집 중· Inflammatory DiseaseInDuctIon TREatment with SubCuTaneous Infliximab for Crohn's Disease
협력: 셀트리온
- 1상완료· SARS-CoV-2 InfectionTo Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects
리드: 셀트리온
- 단계 미표기상태 미확인· Inflammatory Bowel DiseasesA 24-month Real Life PErsistence Efficacy and Safety Study in IBD Patients in REMission Switched From Intravenous Infliximab to Subcutaneous Infliximab CT-P13 Remsima®SC
협력: 셀트리온
- 1상완료· Health, SubjectiveA Drug-Drug Interaction Study of CTL0901 and CTL0902 Compared to Coadministration in Healthy Adult Volunteers
리드: 셀트리온
- 1상완료· Health, SubjectiveA Drug-Drug Interaction Study of CTL0801 and CTL0802 Compared to Coadministration in Healthy Adult Volunteers
리드: 셀트리온
- 3상완료· Diabetic Macular Edema (DME)Study to Compare Efficacy and Safety of CT-P42 in Comparison With Eylea in Patients With Diabetic Macular Edema
리드: 셀트리온
- 3상완료· Postmenopausal Women With OsteoporosisA Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis
리드: 셀트리온
- 3상완료· Chronic Spontaneous UrticariaTo Compare Efficacy and Safety of CT-P39 and EU-approved Xolair in Patients With Chronic Spontaneous Urticaria
리드: 셀트리온
- 2상모집 중· Primary CNS LymphomaStudy of Lenalidomide/Rituximab Maintenance for Transplantation Ineligible Patients With PCNSL.
협력: 셀트리온
- 1상조기 종료· Cardiomyopathy, Hypertrophic ObstructiveA Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy
리드: 셀트리온
- 1상완료· Healthy Male SubjectsA Phase I Study to Evaluate the Safety and Pharmacokinetics of CT-P41 and EU-approved Prolia in Healthy Male Subjects
리드: 셀트리온
- 2/3상완료· SARS-CoV-2 InfectionA Phase 2/3 Study to Evaluate the Efficacy and Safety of CT-P59 in Patients With Mild to Moderate SARS-CoV-2 Infection
리드: 셀트리온
- 1상완료· Healthy SubjectsStudy to Compare PK and Safety of Subcutaneous Injection of Ustekinumab and CT-P43 in Healthy Subjects
리드: 셀트리온
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.